Table 6. Multivariable models for assessing adjusted risk factors for pediatric intensive care unit admission in children infected with Mycoplasma pneumoniae, Ohio, USA, 2015–2019*.
| Model | aOR (95% CI) | p value |
|---|---|---|
| Model 1 | ||
| Macrolide resistance | 5.111 (1.248–20.926) | 0.0233 |
| Underlying conditions |
4.238 (1.68–10.694) |
0.002
|
| Model 2 | ||
| Macrolide resistance | 4.964 (1.247–19.762) | 0.023 |
| Any previous visits |
3.625 (1.273–10.323) |
0.0159
|
| Model 3 | ||
| Macrolide resistance | 4.895 (1.227–19.532) | 0.0245 |
| Abnormal respiratory exam |
5.164 (1.37–19.461) |
0.0153
|
| Model 4 | ||
| Macrolide resistance | 4.969 (1.241–19.906) | 0.0235 |
| Any previous antimicrobial drugs |
3.076 (1.332–7.101) |
0.0085
|
| Model 5 | ||
| Macrolide resistance | 4.911 (1.237–19.499) | 0.0237 |
| Any previous nonmacrolide antimicrobial drugs | 2.717 (1.184–6.234) | 0.0183 |
*Bold type indicates statistical significance. aOR, adjusted odds ratio.